Skip Navigation

European Heart Journal 2001 22(6):450-457; doi:10.1053/euhj.1999.2047
Copyright © 2001 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kovac, J.D.
Right arrow Articles by Gershlick, A.H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kovac, J.D.
Right arrow Articles by Gershlick, A.H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Clinical Perspective

How should we detect and manage failed thrombolysis?

J.D. Kovacf1 and A.H. Gershlick

Glenfield Hospital, Leicester, U.K.

f1 Correspondence: J. Kovac, MD, FACC, FESC, Cardiology Division, Glenfield Hospital, Leicester LE3 9QP, U.K.

References

  1. N Engl J Med. 1993;329:673–682[Abstract/Free Full Text]
  2. Anderson JL, Karagounis LA, Califf RM. Meta analysis of five reported studies on the relation of early coronary patency grades with mortality and outcomes after acute myocardial infarction. Am J Cardiol. 1996;78:1–8[ISI][Medline]
  3. Califf RM, Topol EJ, Gersh BJ. From myocardial salvage to patient salvage in acute myocardial infarction, the role of reperfusion therapy. J Am Coll Cardiol. 1989;14:1382–1388[CrossRef][ISI][Medline]
  4. Grines C, Browne KF, Marco J. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction, the Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med. 1993;328:673–679[Abstract/Free Full Text]
  5. Zijlstra F, de Boer MJ, Hoorntje JC. A comparison of immediate angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med. 1993;328:680–684[Abstract/Free Full Text]
  6. Califf RM, Topol EJ, George BS. Characteristics and outcome of patients in whom reperfusion with intravenous tissue type plasminogen activator fails: results of the thrombolysis and angioplasty in myocardial infarction (TAMI IV). J Am Coll Cardiol. 1988;17:1090–1099
  7. White H. Applying the open artery theory: use of predictive survival markers. Eur Heart J. 1998;19:1132–1139[Free Full Text]
  8. Van de Werf F, Topol EJ, Lee KI. Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. Global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries. J Am Med Assoc. 1995;273:1586–1591[Abstract]
  9. Topol EJ, Bates ER, Walton JA. Community hospital administration of intravenous tissue plasminogen activator in acute myocardial infarction: improved timing, thrombolytic efficacy and ventricular function. J Am Coll Cardiol. 1987;10:1173–1177[Abstract]
  10. J Am Med Assoc. 1988;260:2849–2859[Abstract]
  11. J Am Coll Cardiol. 1996;28:1328–1419[CrossRef][ISI][Medline]
  12. Rouleau JL, Moye LA, Pfeffer MA. A comparison of management patterns after acute myocardial infarction in Canada and the United States. N Engl J Med. 1993;328:779–784[Abstract/Free Full Text]
  13. Califf RM, O'Neill W, Stack Stewart RS. Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis. Ann Intern Med. 1988;108:658–662[ISI][Medline]
  14. Lancet. 1993;342:753–770[CrossRef][ISI][Medline]
  15. Kok Meng Yee, Pringle SD. Failure of reperfusion following thrombolysis in acute myocardial infarction: a survey of current views and clinical practice. Br J Cardiol. 1998;5:35–40
  16. Prendergast BD, Shandall A, Buchhalter MB. What do we do when thrombolysis fails? A United Kingdom survey. Int J Cardiol. 1997;61:39–42[CrossRef][ISI][Medline]
  17. Antman EM, Guigliano RP, Gibson CM. Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. Circulation. 1999;21:2720–2732
  18. Huskisson EC. Measurement of pain. Lancet. 1974;II:1127–1131
  19. Buszman P, Szafranek A, Kalarus Z. Use of changes in ST segment elevation for prediction of infarct artery recanalization in acute myocardial infarction. Eur Heart J. 1995;16:1207–1214[Abstract/Free Full Text]
  20. Purcell IF, Newall N, Farrer M. Change in ST segment elevation 60min after thrombolysis initiation predicts clinical outcome as accurately as later changes. Heart. 1997;78:465–471[Abstract/Free Full Text]
  21. Klootwijk P, Langer A, Meij S. Non-invasive prediction of reperfusion and coronary artery patency by continuous ST segment monitoring in GUSTO I trial. Eur Heart J. 1996;17:689–698[Abstract/Free Full Text]
  22. Stewart JT, French JK, Theroux P. Early noninvasive identification of failed reperfusion after intravenous thrombolytic therapy in acute myocardial infarction. J Am Coll Cardiol. 1998;31:1499–1505[Abstract/Free Full Text]
  23. Lavin F, Kane M, Ganon F. Comparison of five cardiac markers in the detection of reperfusion after thrombolysis in acute myocardial infarction. Br Heart J. 1995;73:422–427[Abstract/Free Full Text]
  24. Norris RM, Johnson RN, White HD. Non invasive diagnosis of infarct artery patency after acute myocardial infarction by use of serial plasma troponin T concentrations: importance of measurement of peak levels. Heart. 1995;74:481–485[Free Full Text]
  25. Matetzky S, Freimark D, Chouraqui P. The distinction between coronary and myocardial reperfusion after thrombolytic therapy by clinical markers of reperfusion. J Am Coll Cardiol. 1998;32:1326–1330[Abstract/Free Full Text]
  26. Mounsey JP, Skinner S, Hawkins T. Rescue thrombolysis:alteplase as adjuvant treatment after streptokinase in acute myocardial infarction. Br Heart J. 1995;74:348–353[Abstract/Free Full Text]
  27. Ross AM, Lundergan CF, Rohrbeck SC. Rescue angioplasty after failed thrombolysis: technical and clinical outcomes in a large thrombolysis trial. J Am Coll Cardiol. 1998;31:1511–1517[Abstract/Free Full Text]
  28. Ellis SG, da Silva ER, Heyndrickx G. Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute myocardial infarction. Circulation. 1994;90:2280–2284[Abstract/Free Full Text]
  29. Mazzota G, Protosido SK, Casati E. Myocardial scintigraphy in acute myocardial infarction treated with systemic thrombolysis: how far are we from obtaining reliable information for rescue PTCA? Int J Cardiol. 1998;29:S69–73[CrossRef]
  30. Czitrom D, Karila-Cohen D, Brochet E. Acute assessment of microvascular perfusion patterns by myocardial contrast echocardiography during myocardial infarction: relation to timing and extent of functional recovery. Heart. 1999;81:12–16[Abstract/Free Full Text]
  31. Kaul S. Myocardial contrast echocardiography in acute myocardial infarction: time to test for routine clinical use? Heart. 1999;81:2–5[Free Full Text]
  32. White HD, Cross DB, Williams BF. ‘Rescue’ thrombolysis with intracoronary tissue plasminogen activator for failed thrombolysis with streptokinase for acute myocardial infarction. Am J Cardiol. 1995;75:172–174[CrossRef][ISI][Medline]
  33. Vergheugt FWA, Veen G, de Cock CC. An angiographic study of intracoronary streptokinase versus intravenous tissue plasminogen activator after failed coronary thrombolysis with intravenous streptokinase. J Thrombos Thrombolysis. 1996;3:239–243[Medline]
  34. Drenth JP, Uppelschoten A, Hooghoudt TE. Rescue thrombolysis may work even though primary thrombolysis has failed (Letter). Br Med J. 1998;317:147[Free Full Text]
  35. Brodie BR, Stuckey TD, Wall TC. Importance of time to reperfusion for 30 day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 1998;3:1312–1319
  36. Topol EJ. Toward a new frontiers in myocardial reperfusion therapy, emerging platelet preeminence. Circulation. 1998;97:211–218[Free Full Text]
  37. Topol EJ. Catheter based reperfusion for acute myocardial infarction. Topol EJ. Textbook of Interventional Cardiology. Philadelphia: Saunders; 1999. p. 269–278
  38. Gould HK, Garabedian HD, Dinsmore RE. Restoration of coronary flow in myocardial infarction by intravenous chimeric 7E3 antibody without exogenous plasminogen activators: observations in animals and humans. Circulation. 1997;95:1755–1759[Abstract/Free Full Text]
  39. Belenkie I, Traboulsi M, Hall A. Rescue angioplasty during myocardial infarction has a beneficial effect on mortality: a tenable hypothesis. Can J Cardiol. 1992;8:357–362[ISI][Medline]
  40. Conti CR. Management of myocardial infarction patients with an occluded infarct related artery: additional commentary. Clin Cardiol. 1995;18:243–244[ISI][Medline]
  41. Gibson CM, Canon CP, Greene RM. Rescue angioplasty in Thrombolysis in myocardial infarction (TIMI IV) trial. Am J Cardiol. 1997;80:21–26[CrossRef][ISI][Medline]
  42. Juliard JM, Himbert D, Cristofini P. A matched comparison of prehospital thrombolysis and standby rescue angioplasty with primary angioplasty. Am J Cardiol. 1999;83:305–310[CrossRef][ISI][Medline]
  43. Ward SR, Sutton JM, Pieper KS. Effects of thrombolytic regimen, early catheterization, and predischarge angiographic variables on 6 week left ventricular function. Am J Cardiol. 1997;79:539–544[CrossRef][ISI][Medline]
  44. Madsen JK, Grande P, Saunamaki K. Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). Circulation. 1997;96:748–755[Abstract/Free Full Text]
  45. Grines CL. Transfer of high risk myocardial infarction patients for primary PTCA. J Inv Cardiol. 1997;9:13B–19B
  46. Zijlstra F, vant Hof AWJ, Liem AL. Transferring patients for primary angioplasty, a retrospective analysis of 104 selected high risk patients with acute myocardial infarction. Heart. 1997;78:327–328[Free Full Text]
  47. Broodie D, Stuckey TD, Wall TC. Importance of time to reperfusion for 30 day and late survival and recovery of left ventricular function after primary PTCA for acute myocardial infarction. J Am Coll Cardiol. 1998;32:1312–1319[Abstract/Free Full Text]
  48. Oude Ophuis TJ, Boer FW, Vermeer F. Early referral for intentional rescue PTCA after initiation of thrombolytic therapy in patients admitted to a community hospital because of a large acute myocardial infarction. Am Heart J. 1999;137:846–853[CrossRef][ISI][Medline]
  49. Sutton AGC, Grech ED, Davies A. Experience with salvage angioplasty in a regional cardiothoracic centre using a ‘Hub and Spoke’ referral system. Am J Cardiol. 1998;82:1S[CrossRef][Medline]
  50. Kovac JD, Gershlick AH. Retrieval angioplasty for acute myocardial infarction. An alternative which makes sense. J Int Cardiol. 1998;11:4
  51. Makkar R, Goff B, Eigler N. The Effect of glycoprotein IIb/IIIa inhibition without thrombolytic therapy on reperfusion in acute myocardial infarction: results of ReoMI study. Am J Cardiol. 1998;82:86S
  52. Saito T, Taniguchi I, Nakamura S. Pulse spray thrombolysis in acutely obstructed coronary artery in critical situations. Cath Cardiovasc Diagn. 1994;40:101–108[CrossRef]
  53. Topaz O, Miller G, Vetrovec GW. Transluminal extrraction catheter for acute myocardial infarction. Cath Cardiovasc Diagn. 1997;40:291–296[CrossRef][ISI][Medline]
  54. Kaplan BM, Larkin T, Safian RD. Prospective study of extraction atherectomy in patients with acute myocardial infarction. Am J Cardiol. 1996;78:383–388[CrossRef][ISI][Medline]
  55. Rosenschein U, Roth A, Rassin T. Analysis of coronary ultrasound thrombolysis endpoints in acute myocardial infarction (ACUTE) trial. Results of the feasibility phase. Circulation. 1997;95:1411–1416[Abstract/Free Full Text]
  56. Yock PL, Fitzgerald PJ. Catheter based ultrasound thrombolysis. Circulation. 1997;95:1360–1362[Free Full Text]
  57. Shimizu M, Wang QD, Sjoquist PO. The lipid peroxidation inhibitor indenoindole H290/51 protects myocardium at risk of injury induced by ischemia reperfusion. Free Radic Biol Med. 1998;24:726–731[CrossRef][ISI][Medline]
  58. Ambrosio G, Zweier JL, Becker LC. Apoptosis is prevented by administration of superoxide dismutase in dogs with reperfused myocardial infarction. Basic Res Cardiol. 1998;2:94–96
  59. Campo GM, Squadrito F, Campo S. Antioxidant activity of U-83836, a second generation lazaroid, during myocardial ischemia/reperfusion injury. Free Radic Res. 1997;27:577–590[ISI][Medline]
  60. Ohlin H, Pavlidis N, Ohlin AK. Effect of intravenous nitroglycerin on lipid peroxidation after thrombolytic therapy for acute myocardial infarction. Am J Cardiol. 1998;82:1463–1467[CrossRef][ISI][Medline]
  61. Ishihara M, Sato H, Tateishi H. Intraaortic balloon pumping as adjunctive therapy to rescue coronary angioplasty after failed thrombolysis in anterior wall acute myocardial infarction. Am J Cardiol. 1995;76:73–75[CrossRef][ISI][Medline]
  62. Kono T, Morita H, Nishina T. Aortic counterpulsation may improve late patency of the occluded coronary artery in patients with early failure of thrombolytic therapy. J Am Coll Cardiol. 1996;28:876–881[Abstract]
  63. van de Merkhof LF, Zijlstra F, Olsson H. Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous coronary angioplasty. Results of the glycoprotein receptor antagonist patency evaluation (GRAPE) study. J Am Coll Cardiol. 1999;33:1528–1532[Abstract/Free Full Text]
  64. Miller JM, Smalling R, Ohman EM. Effectiveness of early coronary angioplasty and abciximab for failed thrombolysis (reteplase or alteplase) during acute myocardial infarction (results from the GUSTO-III trial). Am J Cardiol. 1999;8:779–784

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 ANGIOLOGYHome page
L. H. Reisin, N. Pancheva, M. Berman, V. Khalameizer, J. Jafary, C. Yosefy, Y. Blaer, I. Manevich, R. Peled, and S. Scharf
Circadian Variation of the Efficacy of Thrombolytic Therapy in Acute Myocardial Infarction--Isn't the Time Ripe for Cardiovascular Chronotherapy?
Angiology, May 1, 2004; 55(3): 257 - 263.
[Abstract] [PDF]

Home page
 Br Med BullHome page
A H Gershlick
The acute management of myocardial infarction
Br. Med. Bull., October 1, 2001; 59(1): 89 - 112.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kovac, J.D.
Right arrow Articles by Gershlick, A.H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kovac, J.D.
Right arrow Articles by Gershlick, A.H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?